Association of Epstein-Barr virus with human immunodeficiency virus-negative peripheral T-cell lymphomas in Japan

European Journal of Haematology

Volumn 76, Issue 2, 2006, Pages 109-118

  Hirose, Yuko ^a   Masaki, Yasufumi ^a   Sawaki, Toshioki ^a   Shimoyama, Kumiko ^a   Karasawa, Hiromi ^a   Kawabata, Hiroshi ^a   Fukushima, Toshihiro ^a   Ogawa, Noriyoshi ^a   Wano, Yuji ^a   Umehara, Hisanori ^a  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

Epstein Barr virus encoded RNA in situ hybridization (EBER ISH); Latent membrane protein; NK T cell lymphoma; Peripheral T cell lymphoma; Polymerase chain reaction

Indexed keywords

DNA; FORMALDEHYDE; LATENT MEMBRANE PROTEIN 1; MONOCLONAL ANTIBODY; PARAFFIN;

ADOLESCENT; ADULT; AGED; ANALYTIC METHOD; ANGIOIMMUNOBLASTIC LYMPHADENOPATHY; ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IN SITU HYBRIDIZATION; INCIDENCE; JAPAN; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER T CELL; PERIPHERAL T CELL LYMPHOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; BASE SEQUENCE; DNA PROBES; FEMALE; HERPESVIRUS 4, HUMAN; HIV SERONEGATIVITY; HUMANS; IN SITU HYBRIDIZATION; JAPAN; LYMPHOMA, T-CELL; MALE; MIDDLE AGED; PARAFFIN EMBEDDING; POLYMERASE CHAIN REACTION;

EID: 33645082489     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.0902-4441.2005.00575.x     Document Type: Article

References (33)

1. A scani S Z inzani PL G herlinzoni F et al. Peripheral T-cell lymphpmas. Clinico-pathologic study of 168 cases diagnosed according to the R.E.A.L. classification Ann Oncol 1997 8 583 592
2. A nonymous A clinical evaluation of the International Lymphoma Study Group Classification of non-Hodgkin's lymphoma The non-Hodgkin's Lymphoma Classification Project Blood 1997 89 3909 3918
3. Lymphoma Study Group of Japanese Pathologists The World Health Organization classification of malignant lymphomas in Japan: incidence of recently recognized entities Patho Int 2000 50 696 702
4. G allamini A S telitano C C alvi R et al. Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study Blood 2004 103 2474 2479
5. A nonymous National Cancer Institute sponsored study of classification of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage Non-Hodgkin's Lymphoma Pathologic Classification Project Cancer 1982 49 212
6. J affe ES R alfkiaer E Mature T-cell and NK-cell neoplasms In J affe ES H arris NL S tein H V ardiman JW eds WHO Classification: Tumours of Haematopoietic and Lymphoid Tissues
7. C han J N g C L au W L o S Most nasal/nasopharyngeal lymphomas are peripheral T-cell neoplasms Am J Surg Pathol 1987 11 418
8. J affe ES Classification of natural killer (NK) cell and NK-like T-cell malignancies Blood 1996 87 1207 1210
9. J affe ES C han JKC S u I-J F rizzera G M ori S F eller AC H o FCS Report of the workshop on nasal and related extranodal angiocentric T/natural killer cell lymphomas Am J Surg Patho 1996 20 103 111
10. N akamura S K atoh E Y atabe Y et al. Clinicopathologic study of nasal T/NK-cell lymphoma among the Japanese Pathol Int 1997 47 38 53
11. C heung MM C han JK L au WH et al. Primary non-Hodgkin's lymphoma of the nose and nasopharynx: clinical features tumor immunophenotype, and treatment outcome in113 patients J Clin Oncol 1998 16 70 77
12. C heung MMC C han JK W ong KF Natural killer cell neoplasms: a distinct group of highly aggressive lymphomas/leukemias Semin Hematol 2003 40 221 232
13. L i CC T ien JL Y ao M C hen YC S u IJ H su SM H ong RL Treatment outcome and pattern of failure in 77 patients with sinonasal natural/T-cell or T-cell lymphoma Cancer 2004 100 366 375
14. H irai K H ironaka T K awa -H a K I noue M M orishima T Y amamoto M O ishi T A rai T Application of PCR to various clinical specimens for detection of Epstein-Barr virus and its evaluation Clin Virol 1994 22 320 326
15. M ies C Molecular pathology of paraffin-embedded tissue. Current clinical application Diagn Mol Pathol 1992 1 206 211
16. O da T K anai Y O yama T Y oshiura K S himoyama Y B irchmeier W S ugimura T H irohashi S E-cadherin gene mutations in human gastric carcinoma cell lines Proc Natl Acad Sci USA 1994 91 1858 1862
17. H uh J C ho K H eo DS K im JE K im CW Detection of Epstein-Barr virus in Korean peripheral T-cell lymphoma Am J Hematol 1999 60 205 214
18. Z hou XG H amilton -D utoit SJ Y an QH P allesen G High frequency of Epstein-Barr virus in Chinese peripheral T-cell lymphoma Histopathol 1994 24 115 122
19. K orbjuhn P A nagnostopoulos I H ummel M T iemann M D allenbach F P arwaresch MR S tein H Frequent latent Epstein-Barr virus infection of neoplastic T cells and bystander B cells in human immunodeficiency virus-negative European peripheral pleomorphic T-cell lymphomas Blood 1993 82 217 223
20. C han JKC Y ip TTC T sang WYW N g CS L au WH P oon YF W ong CCS M a VWS Detection of Epstein-Barr viral RNA in malignant lymphomas of upper aerodigestive tract Am J Surg Pathol 1994 18 938 946
21. K anavaros P L escs MC B riere J D ivine M G alateau F J oab I B asq J F arcet JP R eyes F G aulard P Nasal T-cell lymphoma: a clinicopathologic entity with peculiar phenotype and with Epstein-Barr virus Blood 1993 81 2685 2695
22. H enderson S R owe M G regory C C arter DC W ang F L ongnecker R K ieff E R ickinson A Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B-cells from programmed cell death Cell 1991 65 1107 1115
23. F arrell C L ee J S hin E C ebrat M C ole PA H ayward SD Inhibition of Epstein-Barr virus-induced growth proliferation by a nuclear antigen EBNA2-TAT peptide Proc Natl Acad Sci USA 2004 101 4625 4630
24. K ennedy G K omano J S ugden B Epstein-Barr virus provides a survival factor to Burkitt's lymphoma Proc Natl Acad Sci USA 2003 100 14269 14274
25. L i T H ongyo T S yaifudin M N omura T D ong Z S hingu N K ojya S N akatsuka S A ozasa K Mutations in the p53 gene in nasal NK/T-cell lymphoma Lab Invest 2000 80 493 499
26. K imura H M orita M Y abuta Y K uzushima K K ato K K ojimaa S M atsuyama T M orishima T Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay J Clin Microbiol 1999 37 132 136
27. van B aarle D H ovenkamp E C allan MFC et al. Dysfunctional Epstein-Barr virus (EBV)-specific CD8+ T lymphocytes and increased EBV load in HIV-1 infected individuals progressing to AIDS-related non-Hodgkin lymphoma Blood 2001 98 146 155
28. L ei KI C hen LY C han WY J ohnson PJ L o YMD Diagnostic and prognotic implications of circulating cell-free Epstein-Barr virus DNA in natural killer/T-cell lymphoma Clin Cancer Res 2003 8 29 34
29. K im GE C ho JH Y ang WL et al. Angiocentric lymphoma of the head and neck: patterns of systemic failure after radiation treatment J Clin Oncol 2000 18 54 63
30. K im WS S ong SY h n YC et al. CHOP followed by involved field radiation: is it optimal for localized nasal natural killer/T-cell lymphoma? Ann Oncol 2001 12 349 352
31. Y amaguchi M O gawa S N omoto Y et al. Treatment outcome of nasal NK-cell lymphoma: a report of 12 consecutively-diagnosed cases and review of the literature J Clin Exp Hematopathol 2001 41 93 99
32. N agafuji K F ujisaki T A rima F O hshima K L-asparaginase induced durable remission of relapsed nasal NK/T-cell lymphoma after autologous peripheral blood stem cell transplantation Int J Hematol 2001 74 447 450
33. S asaki M M atue K T akeuchi M M itome M H irose Y Successful treatment of disseminated nasal NK/T-cell lymphoma using double autologous peripheral blood stem cell transplantation Int J Hematol 2000 71 75 83